THERESA JENSEN: Open Payments
NPI 1639569916 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 40 payments from 15 companies in 2025. Trend: 2023 $925 · 2024 $903 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $368 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Novo Nordisk Inc | 4 | $79 |
| PFIZER INC. | 2 | $54 |
| Lundbeck LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
Products named: QULIPTA, UBRELVY, Auvelity, ELIQUIS, Rybelsus, REXULTI, Wegovy, CAPLYTA.
Industry payments across MI — which companies pay providers there.
